Patrizia Cavazzoni, key FDA official, to leave agency
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is one of several announced by high-ranking FDA leaders ahead of the coming ...
Hosted on MSN16d
FDA CDER director Patrizia Cavazzoni announces resignation
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
STAT17d
Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency
Patrizia Cavazzoni, leader of the Food and Drug Administration ... will take Cavazzoni’s place pending ethics clearance, FDA Commissioner Robert Califf said in an email reviewed by STAT.
FiercePharma17d
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire from the agency. The seven-year FDA veteran communicated the decision in ...
Becker's Hospital Review17d
FDA drug evaluation leader to exit
The director of the FDA's Center for Drug Evaluation and Research, Patrizia Cavazzoni, MD, will step down from the role Jan. 18, according to an Endpoints News report. Dr. Cavazzoni joined the FDA ...
JD Supra6d
Drugs and Biologics at FDA: Reflections on 2024 Activity Shed Light on the Road Ahead
With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...
Benzinga.com17d
Patrizia Cavazzoni, head of FDA's drug center, to leave the agency
Patrizia Cavazzoni, leader of the Food and Drug Administration’s Center for Drug Evaluation and Research, is leaving the agency on Jan. 18. The director shared the news with staff on Friday ...